Vijaya Diagnostic Q2 profit rises 37.4%, revenue up 26.7%

Vijaya Diagnostic Q2 profit rises 37.4% and revenue grows 26.7%. Shares turn volatile, with Rs 1,600 resistance and Rs 1,330 support in focus. Vijaya Diagnostic Centre Limited [

] reported strong consolidated Q2 results for the September quarter, with net profit increasing 37.4% year on year to Rs 59.5 crore from Rs 43.3 crore. Revenue also grew 26.7% to Rs 255.4 crore compared with Rs 201.6 crore in the corresponding quarter last year. Despite the healthy quarterly performance, the stock witnessed significant volatility in today's trading session. Shares moved to a one-month high before facing selling pressure and trading in the red. The latest price action has also engulfed the entire trading range of the previous six sessions, indicating increased volatility following the quarterly results. From a technical perspective, Rs 1,600 is an important resistance zone, positioned just above the previous all-time high and near a psychological price level. On the downside, Rs 1,330 remains an important support in the near term. The broader technical structure remains sideways to bullish. A sustained move above the resistance zone could strengthen the upward momentum, while holding support remains crucial for maintaining the positive bias. Disclaimer: I do not hold any position in this stock. This is not a recommendation to buy or sell. Investments in securities markets are subject to market risks. Read all related documents carefully before investing.